Navigation Links
Preclinical Data Show Alfacell's Onconase Inhibits Tumor Growth of,Non-Small Cell Lung Cancer, Breast Cancer Cells

Poster Presented at AACR Annual Meeting

BLOOMFIELD, N.J., April 16, 2007 /PRNewswire-FirstCall/ -- Alfacell Corporation today announced that in vivo and in vitro preclinical data presented in a poster at the American Association for Cancer Research (AACR) Annual Meeting show that ONCONASE (ranpirnase) significantly inhibits tumor growth of non-small cell lung cancer (NSCLC) and breast cancer cells.

In the poster titled "Increased apoptosis and reduced lactate levels by ranpirnase in human lung and breast cancer", Intae Lee, Ph.D. and collaborators at the University of Pennsylvania demonstrated that ONCONASE significantly inhibited tumor growth by inducing apoptosis (cell death) in A549 and NCI-H1975 human NSCLC cells and MDA-MB-231 and MCF-7 human breast cancer cells without damaging non-cancerous cells such as HLF-1 human lung fibroblast and NCI/3T3 fibroblast. Additionally, the data indicated that twice weekly injections of ONCONASE were more effective than an equivalent single dose injection in these tumor types.

"The findings of our investigation suggest important potential clinical uses of ONCONASE for the treatment of NSCLC and breast cancer," said Dr. Lee.

Kuslima Shogen, Alfacell's chairman and chief executive officer, added: "This research adds to the extensive published data that supports our continued development of ONCONASE for multiple cancer indications. The ONCONASE franchise includes the gateway indication of malignant mesothelioma and several other tumor types for which we are continuing preclinical and clinical studies."

About ONCONASE(R)

ONCONASE is a first-in-class therapeutic product candidate based on Alfacell's proprietary ribonuclease (RNase) technology. A natural protein isolated from the leopard frog, ONCONASE has been shown in the laboratory and clinic to target cancer cells while sparing normal cells. ONCONASE triggers apoptosis, the natural death o
'"/>




Page: 1 2 3

Related medicine technology :

1. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
2. Gene Therapy Eradicates Pancreatic Cancer in Preclinical Trial Targeting Systems Success in Mouse Model Reported in Cancer Cell
3. YM BioSciences Announces Preclinical Data Confirming Nimotuzumab Binds to the EGF Receptor and Potentiates Radiotherapy
4. ZIO-101 (Darinaparsin) Interim Phase II and Preclinical Data Presented at International Myeloma Workshop
5. ACE-011 Improves Multiple Myeloma Bone Disease in a Preclinical Model
6. Publication on Pixantrone Preclinical Studies Demonstrates Reduced Cardiotoxicity Compared to Equiactive Doses of Doxorubicin and Mitoxantrone
7. Genaera Presents Preclinical Data on Trodusquemine (MSI-1436) for the Treatment of Obesity at the American Diabetes Association 67th Scientific Session
8. Elixir Pharmaceuticals Presents Preclinical Data Highlighting Its Ghrelin Antagonist Program at the American Diabetes Associations Annual Meeting
9. Genaera to Present Preclinical Data on Trodusquemine for the Treatment of Obesity at the American Diabetes Association 67th Scientific Sessions
10. Metabasis Therapeutics Presents Results of Preclinical Studies for MB07811, Its Novel Product Candidate for the Treatment of Hyperlipidemia, at the Endocrine Societys Annual Meeting
11. Elixir Pharmaceuticals Presents Additional Preclinical Data Demonstrating the Potential of Ghrelin Antagonism to Regulate Metabolism, Body Weight and Glycemic Control
Post Your Comments:
(Date:9/17/2014)... , Sept. 17, 2014   MedeAnalytics ... solution that brings complete visibility to a provider,s ... an ever-evolving reimbursement landscape. Powered by the industry,s ... to the critical point between patient access and ... The solution will improve revenue capture, minimize audit ...
(Date:9/17/2014)... , Sept. 17, 2014  The law ... today announced that it will serve as host ... and Avoiding the Risks of Healthcare Reform," a ... will examine delivery systems, reimbursement, compliance and enforcement ... Act. Logo -  http://photos.prnewswire.com/prnh/20140916/146606 ...
(Date:9/17/2014)... , Sept. 17, 2014 Cardiac Dimensions ... data from the TITAN II clinical trial of ... and sustained improvements in mitral regurgitation, functional improvement, ... long-term safety and efficacy data, which was consistent ... Sept. 13 at the 26 th annual ...
Breaking Medicine Technology:MedeAnalytics Unveils New Revenue Integrity Solution to Support the Transition to Value-Based Healthcare 2MedeAnalytics Unveils New Revenue Integrity Solution to Support the Transition to Value-Based Healthcare 3Three Leading Healthcare Organizations Sponsor Conference to Examine Opportunities and Risks of Healthcare Reform for Providers 2Cardiac Dimensions Announces New Long-Term Outcomes Data From TITAN II Clinical Trial Demonstrates Safety, Efficacy Of Enhanced CARILLON Mitral Contour System 2Cardiac Dimensions Announces New Long-Term Outcomes Data From TITAN II Clinical Trial Demonstrates Safety, Efficacy Of Enhanced CARILLON Mitral Contour System 3
... BioSpecifics Technologies Corp. (Nasdaq: BSTC ), ... today announced that BioSpecifics, President, Tom Wegman, will present ... Conference on Friday, October 22, 2010 at 3:00 pm ... New York. A live webcast of ...
... Network, already the largest distributor of FDA-approved drug ... that this month it will surpass six million ... ("REMS") program alerts delivered to prescribers. FDA-approved Drug-Alerts ... Network,s Health Care Notification Network (HCNN) service since ...
Cached Medicine Technology:PDR Network Delivers Six Million Drug Alerts & REMS 2PDR Network Delivers Six Million Drug Alerts & REMS 3
(Date:9/17/2014)... 17, 2014 As kinship care continues ... who cannot live with their parents, emphasis on kinship ... to enhance services and supports for kinship caregivers and ... National Kinship Care Conference is being held this week ... best practice, policy, program and service development for kinship ...
(Date:9/17/2014)... infection may be preventable with a vaccine, new research ... researchers at Washington University School of Medicine in St. ... tubes used in hospitals and other care facilities to ... day a catheter is present in the urethra and ... Nearly every patient who has a catheter for more ...
(Date:9/17/2014)... News) -- Social networking sites can help people lose ... who are obese, sites like Twitter and Facebook can ... doctors as well as peers, researchers found. "One ... that it offers the potential to be much more ... to traditional approaches," the study,s lead author, Dr. Hutan ...
(Date:9/17/2014)... 2014 In Pretrial Order #139 (Scheduling ... discovery conferences would be beneficial in this [MDL].” Accordingly, ... “At the end of December,” the order further provides, ... additional conferences. , “The plain import of this ... still much to be discussed as these cases progress ...
(Date:9/17/2014)... News) -- Positive messages about the health benefits of ... a new study suggests. Although smokers who think ... about the harmful effects of smoking, researchers found smokers ... more from "gain-framed," or positive, messages about how quitting ... using a mix of both types of messages might ...
Breaking Medicine News(10 mins):Health News:Arizona’s Children Association Kinship Service Providers Invited to Present at the CWLA National Conference 2Health News:In mice, vaccine stops urinary tract infections linked to catheters 2Health News:In mice, vaccine stops urinary tract infections linked to catheters 3Health News:Social Networking Sites Can Help Obese Lose Weight: Study 2Health News:Transvaginal Mesh Lawsuit News: New Order in C.R. Bard MDL Sets Schedule of Conferences for September to December, the Rottenstein Law Group LLP Reports 2Health News:More Than One Kind of Message May Convince Smokers to Quit, Study Says 2
... A newly published report reveals patients with epilepsy and ... uncontrolled seizures, drug-related side effects, and a lower overall ... SES patients used the hospital emergency room more often ... epileptic patients at higher socioeconomic levels. Full findings are ...
... be a helpless and heartbreaking situation for families as they ... What they may not know is that there,s a society ... from this dangerous and possibly fatal behavior. University ... of social support group as social networks grow on the ...
... Hospital of Rhode Island has been named a Center ... Institute of OptumHealth, an independent audit company. According ... equal. For complex medical conditions, the disparity is ... developed Centers of Excellence networks that provide access to ...
... some 19th century Mormon men had the curious effect of ... marriages, say scientists from Indiana University Bloomington and three other ... Human Behavior . Simply put, the more sister-wives a ... produce. "Although it,s great in terms of number of ...
... to trauma patients, according to a study published in the ... have death rates that are 34 percent lower, while spending ... hospitals, suggesting high quality can coexist with lower cost. ... The research comes at a time when the affordability of ...
... HealthDay Reporter , MONDAY, Feb. 21 (HealthDay News) ... heavily on the emotional lives of women than men, a ... imply that women need additional care, including follow-up and possibly ... by Dr. Cynthia Holterhues of the department of dermatology ...
Cached Medicine News:Health News:Health care disparities seen in epilepsy patients with low socioeconomic status 2Health News:Research uncovers a secret society connecting through the Internet 2Health News:Women & Infants named Center of Excellence for Neonatal Care for fifth year 2Health News:Polygamy hurt 19th century Mormon wives' evolutionary fitness 2Health News:Polygamy hurt 19th century Mormon wives' evolutionary fitness 3Health News:High-quality care associated with lower cost in trauma 2Health News:Surviving Melanoma May Take Different Toll on Women, Men 2Health News:Surviving Melanoma May Take Different Toll on Women, Men 3
Used for retrograde pyelogram. The tip configuration occludes the ureteral orifice and stabilizes the catheter by temporarily wedging in the orifice. Supplied sterile in peel-open packages. Intended ...
... for the injection of contrast medium, anesthetic ... lumen design eliminates the need for multiple ... promote atraumatic passage into and through the ... hydrophilic polymer that when activated, attracts and ...
Used for drainage and retrograde pyelogram. Supplied sterile in peel-open packages. Intended for one-time use....
... two staggered eyes. It is made ... adapter is enclosed. They are color ... right. They are for single use, ... length is 65cm and they are ...
Medicine Products: